Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Rettenmaier

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Gynecologic Oncology|November 1, 1984
The subrenal capsule tumor implant assay as a predictor of clinical response to chemotherapy: 3 years of experienceJ A Stratton, P R Kucera, J P Micha, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2013
Pegfilgrastim safely administered on the same day as dose-dense chemotherapy for patients with advanced-stage ovarian carcinomaJ P Micha, J V Brown, M A Rettenmaier, et al.
Progress in Clinical and Biological Research|January 1, 1984
Gynecologic uses of photoradiation therapyM A Rettenmaier, M L Berman, P J Disaia, et al.
Cancer|April 1, 1988
Treatment of advanced and recurrent squamous carcinoma of the uterine cervix with constant intraarterial infusion of cisplatinM A Rettenmaier, M F Moran, N F Ramsinghani, et al.
Gynecologic Oncology|March 1, 1990
Whole-abdominal radiotherapy for patients with minimal residual epithelial ovarian cancerP R Kucera, M L Berman, P Treadwell, et al.
Cancer|June 1, 1989
Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage 1B cervical cancerM A Rettenmaier, D M Casanova, J P Micha, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 9, 2007
A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancerJ P Micha, B H Goldstein, M A Rettenmaier, et al.
Gynecologic Oncology|November 1, 1986
Accurate laboratory predictions of the clinical response of patients with advanced ovarian cancer to treatment with cyclophosphamide, doxorubicin, and cisplatinJ A Stratton, P R Kucera, M A Rettenmaier, et al.
Gynecologic Oncology|December 6, 2000
A phase I trial of a 3-day topotecan Q 21 days for recurrent epithelial cancers of the ovary, fallopian tube, and peritoneumJ V Brown, W A Peters, M A Rettenmaier, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Gynecologic Oncology|November 1, 1984
The subrenal capsule tumor implant assay as a predictor of clinical response to chemotherapy: 3 years of experienceJ A Stratton, P R Kucera, J P Micha, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2013
Pegfilgrastim safely administered on the same day as dose-dense chemotherapy for patients with advanced-stage ovarian carcinomaJ P Micha, J V Brown, M A Rettenmaier, et al.
Progress in Clinical and Biological Research|January 1, 1984
Gynecologic uses of photoradiation therapyM A Rettenmaier, M L Berman, P J Disaia, et al.
Cancer|April 1, 1988
Treatment of advanced and recurrent squamous carcinoma of the uterine cervix with constant intraarterial infusion of cisplatinM A Rettenmaier, M F Moran, N F Ramsinghani, et al.
Gynecologic Oncology|March 1, 1990
Whole-abdominal radiotherapy for patients with minimal residual epithelial ovarian cancerP R Kucera, M L Berman, P Treadwell, et al.
Cancer|June 1, 1989
Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage 1B cervical cancerM A Rettenmaier, D M Casanova, J P Micha, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 9, 2007
A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancerJ P Micha, B H Goldstein, M A Rettenmaier, et al.
Gynecologic Oncology|November 1, 1986
Accurate laboratory predictions of the clinical response of patients with advanced ovarian cancer to treatment with cyclophosphamide, doxorubicin, and cisplatinJ A Stratton, P R Kucera, M A Rettenmaier, et al.
Gynecologic Oncology|December 6, 2000
A phase I trial of a 3-day topotecan Q 21 days for recurrent epithelial cancers of the ovary, fallopian tube, and peritoneumJ V Brown, W A Peters, M A Rettenmaier, et al.
Pageof 5